Evidence map›Paper›PMID 30654527›Full record

ReviewNon-coding RNA2019

Factors Regulating microRNA Expression and Function in Multiple Myeloma.

Irena Misiewicz-Krzeminska, Patryk Krzeminski, Luis A Corchete, Dalia Quwaider, Elizabeta A Rojas, Ana Belén Herrero, Norma C Gutiérrez

Open access · goldAbstract readReview
In one paragraph

Review in Non-coding RNA, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. InhibitingBiomedicines · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Study of Small Non-Coding RNA (miRNA) Expression Pattern of Fertile/Infertile Male Semen.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2022
    Article
  13. Review
  14. [Diagnostic and prognostic value of serum miR-19a-3p in patients with multiple myeloma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Irena Misiewicz-KrzeminskaThe Institute for Biomedical Research (IBSAL), 37007 Salamanca, Spain. irenamk@usal.es.ORCID 0000-0002-4206-8586
Patryk KrzeminskiThe Institute for Biomedical Research (IBSAL), 37007 Salamanca, Spain. patrykk@usal.es.
Luis A CorcheteThe Institute for Biomedical Research (IBSAL), 37007 Salamanca, Spain. lacorsan@usal.es.ORCID 0000-0003-4577-8599
Dalia QuwaiderThe Institute for Biomedical Research (IBSAL), 37007 Salamanca, Spain. dalia@usal.es.
Elizabeta A RojasThe Institute for Biomedical Research (IBSAL), 37007 Salamanca, Spain. elirr@usal.es.
Ana Belén HerreroThe Institute for Biomedical Research (IBSAL), 37007 Salamanca, Spain. anah@usal.es.
Norma C GutiérrezThe Institute for Biomedical Research (IBSAL), 37007 Salamanca, Spain. normagu@usal.es.
Instituto de Investigación Biomédica de Salamanca · ESUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intensive research has been undertaken during the last decade to identify the implication of microRNAs (miRNAs) in the pathogenesis of multiple myeloma (MM). The expression profiling of miRNAs in MM has provided relevant information, demonstrating different patterns of miRNA expression depending on the genetic abnormalities of MM and a key role of some miRNAs regulating critical genes associated with MM pathogenesis. However, the underlying causes of abnormal expression of miRNAs in myeloma cells remain mainly elusive. The final expression of the mature miRNAs is subject to multiple regulation mechanisms, such as copy number alterations, CpG methylation or transcription factors, together with impairment in miRNA biogenesis and differences in availability of the mRNA target sequence. In this review, we summarize the available knowledge about the factors involved in the regulation of miRNA expression and functionality in MM.

Indexed as

methylationmiRNAmiRNA regulationmyeloma multiple

Identifiers

PMID30654527
PMCPMC6468559
OpenAlexW2909876769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.